BACKGROUND: The effect of long-chain polyunsaturated fatty acid (LCPUFA) intake on cognitive development is controversial. Most randomized trials have assessed cognition at 18 mo, although significant development of cognitive abilities (early executive function) emerge later. OBJECTIVE: The objective was to evaluate cognition beyond 18 mo and longitudinal cognitive change from 18 mo to 6 y in children who were fed variable amounts of docosahexaenoic acid (0.32%, 0.64%, and 0.96% of total fatty acids) and arachidonic acid (ARA; 0.64%) compared with children who were not fed LCPUFA as infants. DESIGN:Eighty-one children (19 placebo, 62 LCPUFA) who participated in a double-blind, randomized trial of LCPUFA supplementation as infants were re-enrolled at 18 mo and tested every 6 mo until 6 y on age-appropriate standardized and specific cognitive tests. RESULTS:LCPUFA supplementation did not influence performance on standardized tests of language and performance at 18 mo; however, significant positive effects were observed from 3 to 5 y on rule-learning and inhibition tasks, the Peabody Picture Vocabulary Test at 5 y, and the Weschler Primary Preschool Scales of Intelligence at 6 y. Effects of LCPUFAs were not found on tasks of spatial memory, simple inhibition, or advanced problem solving. CONCLUSIONS: The data from this relatively small trial suggest that, although the effects of LCPUFAs may not always be evident on standardized developmental tasks at 18 mo, significant effects may emerge later on more specific or fine-grained tasks. The results imply that studies of nutrition and cognitive development should be powered to continue through early childhood. This parent trial was registered at clinicaltrials.gov as NCT00266825.
RCT Entities:
BACKGROUND: The effect of long-chain polyunsaturated fatty acid (LCPUFA) intake on cognitive development is controversial. Most randomized trials have assessed cognition at 18 mo, although significant development of cognitive abilities (early executive function) emerge later. OBJECTIVE: The objective was to evaluate cognition beyond 18 mo and longitudinal cognitive change from 18 mo to 6 y in children who were fed variable amounts of docosahexaenoic acid (0.32%, 0.64%, and 0.96% of total fatty acids) and arachidonic acid (ARA; 0.64%) compared with children who were not fed LCPUFA as infants. DESIGN: Eighty-one children (19 placebo, 62 LCPUFA) who participated in a double-blind, randomized trial of LCPUFA supplementation as infants were re-enrolled at 18 mo and tested every 6 mo until 6 y on age-appropriate standardized and specific cognitive tests. RESULTS: LCPUFA supplementation did not influence performance on standardized tests of language and performance at 18 mo; however, significant positive effects were observed from 3 to 5 y on rule-learning and inhibition tasks, the Peabody Picture Vocabulary Test at 5 y, and the Weschler Primary Preschool Scales of Intelligence at 6 y. Effects of LCPUFAs were not found on tasks of spatial memory, simple inhibition, or advanced problem solving. CONCLUSIONS: The data from this relatively small trial suggest that, although the effects of LCPUFAs may not always be evident on standardized developmental tasks at 18 mo, significant effects may emerge later on more specific or fine-grained tasks. The results imply that studies of nutrition and cognitive development should be powered to continue through early childhood. This parent trial was registered at clinicaltrials.gov as NCT00266825.
Authors: Elizabeth L Prado; John Phuka; Kenneth Maleta; Per Ashorn; Ulla Ashorn; Steve A Vosti; Kathryn G Dewey Journal: Matern Child Health J Date: 2016-10
Authors: L M Currie; E A Tolley; J M Thodosoff; E H Kerling; D K Sullivan; J Colombo; S E Carlson Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2015-04-17 Impact factor: 4.006
Authors: Ke Liao; Bruce D McCandliss; Susan E Carlson; John Colombo; D Jill Shaddy; Elizabeth H Kerling; Rebecca J Lepping; Wichian Sittiprapaporn; Carol L Cheatham; Kathleen M Gustafson Journal: Dev Sci Date: 2016-10-16
Authors: Rebecca J Lepping; Robyn A Honea; Laura E Martin; Ke Liao; In-Young Choi; Phil Lee; Vlad B Papa; William M Brooks; D Jill Shaddy; Susan E Carlson; John Colombo; Kathleen M Gustafson Journal: Dev Psychobiol Date: 2018-10-11 Impact factor: 3.038
Authors: John Colombo; Kathleen M Gustafson; Byron J Gajewski; D Jill Shaddy; Elizabeth H Kerling; Jocelynn M Thodosoff; Tasha Doty; Caitlin C Brez; Susan E Carlson Journal: Pediatr Res Date: 2016-06-30 Impact factor: 3.756